semaglutide approved by fda Clears For Cardiac Risk Reduction in Diabetic Patients Ozempic is first GLP-1 drug

GLP-1 therapy helps the body respond better to insulin, which can reduce future risk of type 2 diabetes and cardiovascular disease

GLP-1, in turn, has been revealed to modulate insulin secretion, enhance gastric motility, inhibit food intake, and inhibit glucagon secretion

Another plus is the inclusion of silymarin milk thistle extract, which is known for its liver-protecting properties

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems

*For illustrative purposes only

Options include: Medical-grade travel coolers: These are insulated bags designed specifically for medication transport